AI robots are turbo-charging the race to find new drugs for ALS, also known as Lou Gehrig's disease.
Doctors, astronomers and manufacturers are warning of defective knockoffs flooding the U.S. market as the Aug. 21 event nears.
The sudden bout of volatility followed three weeks of motionlessness.
Closures are up in a field jammed with programs promising to quickly teach students skills needed to get hired as professional coders.
Louis Martin Blazer III took money from professional athletes to fund movies, says the SEC.
MetLife wants to ease the terms under which it can pay dividends or buy back shares.
Advisors who understand Medicare can save clients money—and also possibly their lives.
In a recent report, OPEC points to signs of a stronger oil market.
The DOL wants to give wealth management companies until July 2019 to comply with the new regulation.
The Securities and Exchange Commission has dodged a political hot potato.
If you’d invested in stocks John Malone owned over the past decade, you’d have been richly rewarded.
Demand for tax-exempt debt in the Golden State is called “insatiable."
Companies that don't invest in costly, low-return projects tend to have higher EPS, says Research Affiliates.
A judge threw out thousands of pages of documents she said were illegally seized by the FBI in 2012.
A new survey of almost 1,000 advisors sheds light on what investors are paying and what they get in return.
Black diversity is going backward at several of the biggest U.S. banks, even as it’s grown across corporate America.
Persistent myths might cause people to overlook the value of these products, say advocates.
Americans are drinking more than they used to and alcohol abuse is up.
Fidelity Labs believes Bitcoin and blockchain will transform how we manage our finances.
Many people first find out they are victims of identity theft when they submit their tax returns, says the IRS.